Literature DB >> 33901339

Chronic pain patients' willingness to share personal identifiers on the web for the linkage of medico-administrative claims and patient-reported data: The COPE Cohort.

Anaïs Lacasse1, Véronique Gagnon1, Hermine Lore Nguena Nguefack1, Mélissa Gosselin1, M Gabrielle Pagé2,3, Lucie Blais4, Line Guénette5,6.   

Abstract

PURPOSE: The linkage between patient-reported data and medico-administrative claims is of great interest for epidemiologic research. The goal of this study was to assess the willingness of people living with chronic pain to share personal identifiers on the web for the linkage of medico-administrative and patient-reported data.
METHODS: This methodological investigation was achieved in the context of the implementation of the COPE Cohort. A web-based recruitment initiative targeting adults living with chronic pain was conducted in the province of Quebec (Canada).
RESULTS: A total of 1935 participants completed the questionnaire (mean age: 49.86 ± 13.27; females: 83.69%), 921 (47.60%) of which agreed to data linkage and shared their personal identifiers (name, date of birth, health insurance number) online. The most common reasons for refusal were: concerns regarding data security/privacy (25.71%), and the belief that the requested data were too personal/intrusive (13.52%). Some participants did not understand the relevance of data linkage (11.81%). Participants from the COPE Cohort and those from the subsample who agreed to data linkage were comparable to other random samples of chronic pain individuals in terms of age and pain characteristics.
CONCLUSIONS: Although approximately half of the participants refused data linkage, our approach allowed for the implementation of a data platform that contains a diverse and substantial sample. This investigation has also led to the formulation of recommendations for web-based data linkage, including placing items designed to assess willingness to share personal identifiers at the end of the questionnaire, adding explanatory videos, and using a mixed-mode questionnaire. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  COPE Cohort; acceptability; administrative databases; chronic pain; claims; linkage; methodological recommendations; patient-reported data; personal identifiers; web; willingness

Year:  2021        PMID: 33901339     DOI: 10.1002/pds.5255

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  4 in total

1.  Gender Differences in Medication Adverse Effects Experienced by People Living With Chronic Pain.

Authors:  Hermine Lore Nguena Nguefack; M Gabrielle Pagé; Line Guénette; Lucie Blais; Mamadou Diallo; Marimée Godbout-Parent; Adriana Angarita-Fonseca; Anaïs Lacasse
Journal:  Front Pain Res (Lausanne)       Date:  2022-05-10

2.  Prevalence of cannabis use for pain management in Quebec: A post-legalization estimate among generations living with chronic pain.

Authors:  Marimée Godbout-Parent; Hermine Lore Nguena Nguefack; Adriana Angarita-Fonseca; Claudie Audet; Andréanne Bernier; Ghita Zahlan; Nancy Julien; M Gabrielle Pagé; Line Guénette; Lucie Blais; Anaïs Lacasse
Journal:  Can J Pain       Date:  2022-06-03

3.  Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain: findings from the Chronic Pain & COVID-19 Pan-Canadian Study.

Authors:  Anaïs Lacasse; M Gabrielle Pagé; Lise Dassieu; Nadia Sourial; Audrée Janelle-Montcalm; Marc Dorais; Hermine Lore Nguena Nguefack; Marimée Godbout-Parent; Maria Hudspith; Gregg Moor; Kathryn Sutton; James M Thompson; Manon Choinière
Journal:  Pain Rep       Date:  2021-02-08

4.  Swallowing the pill of adverse effects: A qualitative study of patients' and pharmacists' experiences and decision-making regarding the adverse effects of chronic pain medications.

Authors:  Lise Dassieu; Emilie Paul-Savoie; Élise Develay; Ana Cecilia Villela Guilhon; Anaïs Lacasse; Line Guénette; Kadija Perreault; Hélène Beaudry; Laurent Dupuis
Journal:  Health Expect       Date:  2021-12-21       Impact factor: 3.377

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.